The ear contains a small but significant branch of the vagus nerve — the auricular branch, also called Arnold’s nerve — that provides a non-invasive access point for vagal stimulation. Transcutaneous auricular vagus nerve stimulation (taVNS) uses this branch to activate the same brainstem pathways as implanted VNS devices, without surgery. This guide covers the practical details: where to place electrodes, which devices exist, what parameters the research uses, and what to realistically expect.
The Target: Where the Vagus Nerve Reaches the Ear
The auricular branch of the vagus nerve (ABVN) exits the jugular ganglion, passes through the mastoid canaliculus in the temporal bone, and innervates specific regions of the external ear. Not all parts of the ear contain vagal fibres, and stimulating the wrong area produces no vagal effect.
The cymba conchae — the upper cavity of the concha, above the crus of the helix — has the densest vagal innervation. Functional MRI studies have shown that electrical stimulation of the cymba conchae produces the strongest activation of the nucleus tractus solitarius (NTS), the brainstem relay station that processes all vagal afferent input. This is the primary target for taVNS.
The tragus — the small projection covering the ear canal opening — also receives ABVN innervation and is the target used in many commercial devices because it is easier to clip an electrode onto. fMRI evidence for tragus stimulation shows NTS activation, though generally weaker than cymba conchae stimulation.
The antihelix and the posterior ear canal wall also receive some ABVN innervation. The earlobe, however, has no vagal innervation whatsoever — it is supplied by the great auricular nerve (C2–C3 cervical plexus). This is precisely why clinical studies use earlobe stimulation as the sham (placebo) condition: it delivers identical electrical sensation with no vagal pathway activation.
Parameters That Matter
Clinical taVNS research uses specific electrical parameters. These are not arbitrary — they are selected to preferentially activate A-beta myelinated afferent fibres (which carry tactile and pressure information to the brainstem) while avoiding C fibres (which carry pain signals and may produce different or adverse effects).
Frequency: 20–30 Hz, with 25 Hz being the most commonly used frequency across clinical studies. Lower frequencies (1–10 Hz) and higher frequencies (above 30 Hz) have less supporting evidence for NTS activation.
Pulse width: 200–500 microseconds. A pulse width of 250 microseconds is the most common in research protocols. Wider pulses recruit more nerve fibres but also increase the likelihood of discomfort.
Current intensity: 0.5–5 mA, individually titrated. The standard approach is to increase current gradually until the person feels a clear tingling or prickling sensation without pain. Pain indicates C fibre recruitment, which is counterproductive. Most people find their threshold between 1 and 3 mA.
Duty cycle: typically 30 seconds on, 30 seconds off. Continuous stimulation may cause habituation, where the nerve fibres stop responding to the constant signal. The on-off cycling helps maintain responsiveness.
Session duration: 30–60 minutes per session. The JAMA Network Open 2024 insomnia study used 30-minute sessions twice daily for eight weeks. Depression studies have used 60-minute daily sessions. There is no established evidence that longer sessions produce additional benefit.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Available Devices
Several devices are marketed for auricular vagus nerve stimulation, though regulatory status varies significantly.
The Parasym Nuropod uses AVNT (Auricular Vagus Nerve Transduction) technology and has received Non-Significant Risk designation, meaning it can be studied without IDE (Investigational Device Exemption) requirements. It retails at approximately $900 direct-to-consumer and clips to the tragus. The device allows parameter adjustment within preset ranges.
Generic TENS (transcutaneous electrical nerve stimulation) units can be adapted for ear stimulation with appropriate ear clip electrodes. These are substantially cheaper but were designed for musculoskeletal pain, not taVNS. Key considerations: ensure the unit can output in the 20–30 Hz range at microampere-to-low-milliampere levels, and use purpose-made ear clip electrodes rather than standard adhesive pads. Standard TENS parameters (higher frequencies, wider pulses) are not equivalent to taVNS parameters.
Lenire (by Neuromod) is a bimodal stimulation device specifically for tinnitus that combines tongue stimulation (trigeminal nerve) with auditory tones. It received FDA De Novo clearance in March 2023 based on the TENT-A2 trial. It operates through a different mechanism than standard taVNS — activating the trigeminal pathway alongside auditory input to modulate the dorsal cochlear nucleus — and is not a general-purpose vagal stimulation device.
A Practical Session Protocol
Clean the target ear area with an alcohol wipe and allow it to dry completely. Apply a small amount of conductive gel to the electrode contacts — this reduces skin impedance and ensures consistent current delivery. Dry electrodes produce uneven stimulation and can cause skin irritation.
Position the electrode on the cymba conchae (if your device allows) or the tragus. For clip-style electrodes, place one contact on the inner surface and the reference contact on the outer surface of the same structure.
Start at the lowest current setting and increase slowly in small increments. You should feel a clear tingling or gentle pulsing sensation. If you feel sharp pain, stinging, or burning, reduce the current immediately — these sensations indicate you have exceeded the therapeutic range. The target is “noticeable but comfortable.”
Remain still and relaxed during the session. Some people combine taVNS with slow breathing or meditation. There is limited evidence on whether this combination enhances effects, but the practices are compatible and unlikely to interfere with each other.
After the session, remove the electrode and clean the skin. Inspect for redness or irritation. Mild redness at the electrode site is common and typically resolves within an hour. Persistent irritation, blistering, or skin breakdown suggests the current was too high, the electrode contact was poor, or conductive gel was insufficient.
What Does Not Work Through the Ear
A common misconception is that sound therapy, binaural beats, or specific audio frequencies can stimulate the vagus nerve through the ear. They cannot. The auricular branch of the vagus nerve is somatosensory — it detects touch, pressure, and temperature on the skin of the ear. It has no role in hearing or auditory processing whatsoever. Hearing is mediated by the vestibulocochlear nerve (cranial nerve VIII), an entirely separate nerve with different central projections. No sound, regardless of frequency, activates the ABVN.
Similarly, ear massage alone — rubbing or pulling the ear — may activate Arnold’s nerve mechanically and is reported to trigger the Arnold’s ear-cough reflex in 2–4% of people, but it does not produce the sustained, frequency-specific nerve fibre activation that electrical taVNS achieves. It is a qualitatively different stimulus.
Left Ear Versus Right Ear
Most clinical taVNS studies use the left ear exclusively. The rationale is that the right vagus nerve has stronger efferent projections to the sinoatrial node (the heart’s pacemaker), raising theoretical concerns about cardiac effects from right-sided stimulation. In practice, the ABVN carries primarily afferent (sensory) fibres, and the risk of cardiac effects from auricular stimulation on either side appears very low based on available safety data. Nevertheless, until more evidence accumulates, left ear stimulation remains the conservative default, and most device manufacturers recommend it.
Contraindications and Safety
Do not use taVNS with an active ear infection, broken skin at the electrode site, or undiagnosed ear pain. People with implanted cardiac devices (pacemakers, defibrillators) should consult their cardiologist before using any electrical stimulation device near the head and neck, even though the cardiac risk from auricular stimulation appears low.
Pregnancy is listed as a contraindication by most manufacturers due to insufficient safety data, not because of demonstrated harm. People with epilepsy should discuss taVNS with their neurologist — while implanted VNS is an approved epilepsy treatment, the parameters and pathways differ from taVNS, and the relationship is not straightforward.
The most common side effects are local skin irritation, tingling at the electrode site, and occasionally mild headache. Rare side effects include transient dizziness or nausea. The Arnold’s ear-cough reflex — an involuntary cough triggered by stimulation of the ear canal or concha — occurs in a small percentage of people and is harmless but can be startling.
What the Evidence Supports
The strongest current evidence for taVNS comes from the 2024 JAMA Network Open insomnia study, which showed significant sleep quality improvement (PSQI improvement of 8.2 versus 3.9 in the sham group) over eight weeks. Evidence for depression, inflammation, and pain is earlier-stage — promising in small trials but not yet confirmed in large, well-controlled studies. taVNS for POTS (postural orthostatic tachycardia syndrome) is under active investigation (NCT04632134), based on the rationale that POTS involves parasympathetic withdrawal and sympathetic overdrive. Results from these ongoing trials will substantially clarify the clinical utility of taVNS across conditions.
Auricular stimulation is one approach to vagal activation — but understanding why it works requires knowing the full anatomy and physiology. Get the Vagus Nerve & Me eBook for the complete picture of vagal science, from brainstem to gut to immune system.
